Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Aminolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101027276B reveals a continuous aminolysis process for alkyl amino acryl amides, offering superior space-time yields and reduced catalyst deactivation for reliable supply chains.
Patent CN112195203A details enzymatic synthesis of S-2-aminobutanamide. High purity, reduced costs, and scalable pharmaceutical intermediates manufacturing for global supply chains.
Discover the novel synthesis route for Tadalafil via patent CN113880837A. Achieving over 99.9% purity with optimized acyl chlorination and cyclization for cost-effective manufacturing.
Patent CN112481319A reveals a green enzymatic route for carbamate synthesis, offering high purity and cost reduction in pharmaceutical intermediates manufacturing without toxic phosgene.
Patent CN107915720B reveals a greener Vonoprazan route. Discover cost reduction in API intermediate manufacturing and reliable supply chain solutions.
Novel carbazate synthesis patent offers high purity and mild conditions. Reduces toxicity risks and ensures scalable supply chain for pharmaceutical intermediates.
Patent CN104039807A reveals catalyst-free sterol synthesis reducing solvent use. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity.
Patent CN102465157B details enzymatic synthesis of pregabalin intermediate offering high purity and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN112125939B reveals a novel acylation and recrystallization route for 5-deoxy-D-ribose, offering superior purity and scalable production for nucleoside drug synthesis.
Novel patent CN106380435B enables high-purity thiourethane and dibenzyl disulfide co-production with reduced waste and enhanced supply chain reliability for global buyers.
Patent CN101027276A enables continuous aminolysis for alkyl amino acryl amides. Achieve superior purity and cost reduction in fine chemical intermediates manufacturing with scalable technology.
Novel aqueous-based route enhances purity and safety for fotemustine manufacturing, offering significant supply chain stability and cost reduction benefits for global pharmaceutical partners.
Patent CN103619822A reveals a simplified base-catalyzed aminolysis route for producing high-purity pyrazolylcarboxanilides, offering significant cost reduction and supply chain reliability for fungicide manufacturers.
Patent CN100497311C details a high-yield aminolysis process for 2-amino-3-chloro-5-trifluoromethylpyridine, offering superior purity and reduced environmental impact for agrochemical supply chains.
Patent CN114394939A reveals a green 3-step route for cimetidine with >90% yield. Discover cost reduction in pharmaceutical manufacturing and high-purity supply solutions.
Novel mild method for Imatinib production avoiding toxic reagents. High yield, scalable process for pharmaceutical intermediates ensuring supply chain stability.
Novel catalyst-free route for Tadalafil intermediate ensures high purity and supply stability for global pharmaceutical manufacturing partners seeking reliable scale-up.
Patent CN115838346A reveals a streamlined one-pot method for synthesizing N,N'-dialkyl-3,3'-dithiodipropionamide, offering significant cost reduction in biocide manufacturing and enhanced supply chain reliability.
Novel patent CN105330616B reveals efficient Cariprazine route avoiding harsh conditions. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel patent CN119306788A reveals high-purity impurity synthesis. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing significantly.